Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Study of Femring Estrogen Supplementation During Depo-Provera Initiation
This study has been completed.
Study NCT00563576   Information provided by Columbia University
First Received: November 21, 2007   Last Updated: April 14, 2009   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Metrorrhagia
More general conditions related to this trial
Genital Diseases, Female
Hemorrhage
Pathologic Processes
Uterine Diseases
Uterine Hemorrhage
Interventions listed in this trial
Femring
Additional drug interventions recognized in this trial
Estradiol
Estradiol 17 beta-cypionate
Estradiol 3-benzoate
Estradiol valerate
Estrogens
Medroxyprogesterone
Medroxyprogesterone 17-Acetate
Polyestradiol phosphate
More general drug interventions related to this trial
Antineoplastic Agents
Antineoplastic Agents, Hormonal
Contraceptive Agents
Contraceptive Agents, Female
Contraceptive Agents, Male
Contraceptives, Oral
Contraceptives, Oral, Synthetic
Hormones
Hormones, Hormone Substitutes, and Hormone Antagonists
Pharmacologic Actions
Physiological Effects of Drugs
Reproductive Control Agents
Therapeutic Uses
Sponsors listed in this trial
Columbia University
An anonymous Foundation.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services